Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.227 USD
-3.81%
Market Closed
Updated:
May 21, 2024
Sonoma Pharmaceuticals Inc
Total Current Liabilities
|
Sonoma Pharmaceuticals Inc
Total Current Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Total Current Liabilities
$3.1m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Liabilities
$48.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Liabilities
$25.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Liabilities
$40.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Liabilities
$25.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Liabilities
$18.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
See Also
What is Sonoma Pharmaceuticals Inc's Total Current Liabilities?
Total Current Liabilities
3.1m
USD
3.1m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Total Current Liabilities amounts to 3.1m USD.
What is Sonoma Pharmaceuticals Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-5%
-5%
Over the last year, the Total Current Liabilities growth was -22%. The average annual Total Current Liabilities growth rates for Sonoma Pharmaceuticals Inc have been -7% over the past three years , -2% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
